FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

Y. Paalvast; E. Zhou; N. L. Mulder; M. Koehorst; R. Boverhof; K. Willems van Dijk; P. C. N. Rensen; J. A. Kuivenhoven; C. Kremoser; Y. Wang; F. Kuipers; A. K. Groen; J. F. de Boer

doi:10.1016/j.atherosclerosis.2018.06.914

FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

Y. Paalvast, E. Zhou, N. L. Mulder, M. Koehorst, R. Boverhof, K. Willems van Dijk, P. C. N. Rensen, J. A. Kuivenhoven, C. Kremoser, Y. Wang, F. Kuipers, A. K. Groen, J. F. de Boer

Center for Liver, Digestive and Metabolic Diseases (CLDM)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	E10
Number of pages	1
Journal	ATHEROSCLEROSIS
Volume	275
DOIs	https://doi.org/10.1016/j.atherosclerosis.2018.06.914
Publication status	Published - Aug-2018
Event	86th Congress of the European-Atherosclerosis-Society (EAS) - Lisbon, Portugal Duration: 5-May-2018 → 8-May-2018

Access to Document

10.1016/j.atherosclerosis.2018.06.914

Cite this

Paalvast, Y., Zhou, E., Mulder, N. L., Koehorst, M., Boverhof, R., van Dijk, K. W., Rensen, P. C. N., Kuivenhoven, J. A., Kremoser, C., Wang, Y., Kuipers, F., Groen, A. K., & de Boer, J. F. (2018). FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. ATHEROSCLEROSIS, 275, E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

Paalvast, Y. ; Zhou, E. ; Mulder, N. L. ; Koehorst, M. ; Boverhof, R. ; van Dijk, K. Willems ; Rensen, P. C. N. ; Kuivenhoven, J. A. ; Kremoser, C. ; Wang, Y. ; Kuipers, F. ; Groen, A. K. ; de Boer, J. F. / FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. In: ATHEROSCLEROSIS. 2018 ; Vol. 275. pp. E10.

@article{9c1a2935f2b8405e82a7fb9057a1f0b8,

title = "FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice",

author = "Y. Paalvast and E. Zhou and Mulder, {N. L.} and M. Koehorst and R. Boverhof and {van Dijk}, {K. Willems} and Rensen, {P. C. N.} and Kuivenhoven, {J. A.} and C. Kremoser and Y. Wang and F. Kuipers and Groen, {A. K.} and {de Boer}, {J. F.}",

year = "2018",

month = aug,

doi = "10.1016/j.atherosclerosis.2018.06.914",

language = "English",

volume = "275",

pages = "E10",

journal = "ATHEROSCLEROSIS",

issn = "0021-9150",

publisher = "ELSEVIER IRELAND LTD",

note = "86th Congress of the European-Atherosclerosis-Society (EAS) ; Conference date: 05-05-2018 Through 08-05-2018",

}

Paalvast, Y, Zhou, E, Mulder, NL , Koehorst, M, Boverhof, R, van Dijk, KW, Rensen, PCN, Kuivenhoven, JA, Kremoser, C, Wang, Y, Kuipers, F , Groen, AK & de Boer, JF 2018, 'FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice', ATHEROSCLEROSIS, vol. 275, pp. E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. / Paalvast, Y.; Zhou, E.; Mulder, N. L.; Koehorst, M.; Boverhof, R.; van Dijk, K. Willems; Rensen, P. C. N.; Kuivenhoven, J. A.; Kremoser, C.; Wang, Y.; Kuipers, F.; Groen, A. K.; de Boer, J. F.

In: ATHEROSCLEROSIS, Vol. 275, 08.2018, p. E10.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

AU - Paalvast, Y.

AU - Zhou, E.

AU - Mulder, N. L.

AU - Koehorst, M.

AU - Boverhof, R.

AU - van Dijk, K. Willems

AU - Rensen, P. C. N.

AU - Kuivenhoven, J. A.

AU - Kremoser, C.

AU - Wang, Y.

AU - Kuipers, F.

AU - Groen, A. K.

AU - de Boer, J. F.

PY - 2018/8

Y1 - 2018/8

U2 - 10.1016/j.atherosclerosis.2018.06.914

DO - 10.1016/j.atherosclerosis.2018.06.914

M3 - Meeting Abstract

VL - 275

SP - E10

JO - ATHEROSCLEROSIS

JF - ATHEROSCLEROSIS

SN - 0021-9150

T2 - 86th Congress of the European-Atherosclerosis-Society (EAS)

Y2 - 5 May 2018 through 8 May 2018

ER -